Quarterly ResultAug 6, 2026, 04:36 PM
AVITA Medical Faces Going Concern Doubt; Q2 Revenue Up 17.8% to $21.7M
AI Summary
AVITA Medical, Inc. reported its Q2 2026 financial results, with the auditor and management expressing substantial doubt about the company's ability to continue as a going concern for the next twelve months. Despite this, the company secured a new $60 million senior secured credit facility, with $50 million funded, and repaid its previous credit agreement. For the second quarter of 2026, total revenues increased to $21.7 million, and the net loss decreased to $7.7 million compared to the same period last year.
Key Highlights
- Auditor and management expressed substantial doubt about AVITA Medical's ability to continue as a going concern.
- Secured new $60 million senior secured credit facility, with $50 million funded at issuance.
- Total revenues for Q2 2026 increased 17.8% to $21.7 million compared to Q2 2025.
- Net loss for Q2 2026 decreased to $(7.7) million from $(9.9) million year-over-year.
- Net loss per common share for Q2 2026 improved to $(0.25) from $(0.38) year-over-year.
- Cash and cash equivalents were $9.1 million as of June 30, 2026, down from $10.2 million at Dec 31, 2025.
- Total stockholders' deficit widened to $(27.8) million as of June 30, 2026, from $(16.7) million at Dec 31, 2025.
Price Impact
More from RCEL